Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
25738 | 273 | 34.9 | 62% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
76 | 3 | NEUROSCIENCES//DOPAMINE//SEROTONIN | 81359 |
218 | 2 | SEROTONIN//5 HT1A RECEPTOR//5 HT2A RECEPTOR | 20633 |
25738 | 1 | TIANEPTINE//COAXIL//CAS 66981 73 5 | 273 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TIANEPTINE | authKW | 8174738 | 45% | 59% | 123 |
2 | COAXIL | authKW | 255656 | 1% | 57% | 4 |
3 | CAS 66981 73 5 | authKW | 223702 | 1% | 100% | 2 |
4 | 5 HT TRANSPORTER ENCODING PLASMIDS | authKW | 111851 | 0% | 100% | 1 |
5 | 5 HT7 RECEPTOR GABAERGIC | authKW | 111851 | 0% | 100% | 1 |
6 | 5 HYDROXYTRYPTAMINE TYPE 2 RECEPTOR | authKW | 111851 | 0% | 100% | 1 |
7 | ADENOSINERGIC RECEPTORS | authKW | 111851 | 0% | 100% | 1 |
8 | ADORPTIVE STRIPPING VOLTAMMETRY | authKW | 111851 | 0% | 100% | 1 |
9 | ALZHEIMERS DIS RELATED DISORDER STUDIES | address | 111851 | 0% | 100% | 1 |
10 | ANTI DEPRESSANT NONMEM POPULATION PHARMACOKINETIC PRE MARKETING DATABASE | authKW | 111851 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Psychiatry | 4004 | 44% | 0% | 119 |
2 | Pharmacology & Pharmacy | 1314 | 41% | 0% | 112 |
3 | Neurosciences | 864 | 34% | 0% | 92 |
4 | Clinical Neurology | 759 | 24% | 0% | 65 |
5 | Psychology | 105 | 5% | 0% | 13 |
6 | Pathology | 68 | 5% | 0% | 14 |
7 | Behavioral Sciences | 43 | 3% | 0% | 9 |
8 | Medicine, General & Internal | 22 | 6% | 0% | 16 |
9 | Chemistry, Medicinal | 6 | 2% | 0% | 6 |
10 | Social Sciences, Biomedical | 5 | 1% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ALZHEIMERS DIS RELATED DISORDER STUDIES | 111851 | 0% | 100% | 1 |
2 | E0117 INSERM PARIS 5 | 111851 | 0% | 100% | 1 |
3 | ECCELLENZA TOSSICOL ALIMENTARE | 111851 | 0% | 100% | 1 |
4 | EUROPEAN BRAIN COUNCIL | 111851 | 0% | 100% | 1 |
5 | GENET PATHOBIOL PROSTAT TUMOURS | 111851 | 0% | 100% | 1 |
6 | GENET VIRUS ONCOGENES | 111851 | 0% | 100% | 1 |
7 | HOP ST ANNE PARIS | 111851 | 0% | 100% | 1 |
8 | KLIN GASTROENTEROLOGII | 111851 | 0% | 100% | 1 |
9 | NEUROSCI DE C PIGNY PK | 111851 | 0% | 100% | 1 |
10 | POST TERTIARY EDUC | 111851 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 9062 | 5% | 1% | 13 |
2 | CLINICAL NEUROPHARMACOLOGY | 6718 | 4% | 1% | 12 |
3 | ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 6507 | 5% | 0% | 14 |
4 | ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE | 5865 | 4% | 0% | 11 |
5 | EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2411 | 3% | 0% | 7 |
6 | HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL | 1628 | 2% | 0% | 5 |
7 | NEUROPSYCHOBIOLOGY | 1170 | 2% | 0% | 5 |
8 | PRESSE MEDICALE | 1104 | 3% | 0% | 9 |
9 | NEUROPHARMACOLOGY | 956 | 3% | 0% | 9 |
10 | REVUE DE PSYCHOLOGIE APPLIQUEE | 907 | 0% | 1% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WAGSTAFF, AJ , ORMROD, D , SPENCER, CM , (2001) TIANEPTINE - A REVIEW OF ITS USE IN DEPRESSIVE DISORDERS.CNS DRUGS. VOL. 15. ISSUE 3. P. 231 -259 | 66 | 67% | 78 |
2 | MCEWEN, BS , CHATTARJI, S , DIAMOND, DM , JAY, TM , REAGAN, LP , SVENNINGSSON, P , FUCHS, E , (2010) THE NEUROBIOLOGICAL PROPERTIES OF TIANEPTINE (STABLON): FROM MONOAMINE HYPOTHESIS TO GLUTAMATERGIC MODULATION.MOLECULAR PSYCHIATRY. VOL. 15. ISSUE 3. P. 237 -249 | 50 | 46% | 90 |
3 | WILDE, MI , BENFIELD, P , (1995) TIANEPTINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN DEPRESSION AND COEXISTING ANXIETY AND DEPRESSION.DRUGS. VOL. 49. ISSUE 3. P. 411-439 | 54 | 73% | 94 |
4 | KASPER, S , MCEWEN, BS , (2008) NEUROBIOLOGICAL AND CLINICAL EFFECTS OF THE ANTIDEPRESSANT TIANEPTINE.CNS DRUGS. VOL. 22. ISSUE 1. P. 15-26 | 33 | 45% | 58 |
5 | UZBAY, TI , (2008) TIANEPTINE: POTENTIAL INFLUENCES ON NEUROPLASTICITY AND NOVEL PHARMACOLOGICAL EFFECTS.PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. VOL. 32. ISSUE 4. P. 915 -924 | 30 | 41% | 19 |
6 | PROENCA, P , TEIXEIRA, H , PINHEIRO, J , MONSANTO, PV , VIEIRA, DN , (2007) FATAL INTOXICATION WITH TIANEPTINE (STABLON (R)).FORENSIC SCIENCE INTERNATIONAL. VOL. 170. ISSUE 2-3. P. 200-203 | 14 | 93% | 0 |
7 | BERNARD, K , PENELAUD, PF , MOCAER, E , DONAZZOLO, Y , (2011) ABSENCE OF PSYCHOSTIMULANT EFFECTS OF A SUPRATHERAPEUTIC DOSE OF TIANEPTINE A PLACEBO-CONTROLLED STUDY VERSUS METHYLPHENIDATE IN YOUNG HEALTHY VOLUNTEERS.JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. VOL. 31. ISSUE 4. P. 441 -448 | 24 | 47% | 1 |
8 | ZHENG, R , KIM, BH , (2014) PHARMACOKINETIC AND BIOEQUIVALENCE ASSESSMENT OF TWO FORMULATIONS OF TIANEPTINE SODIUM IN HEALTHY MALE VOLUNTEERS.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. VOL. 52. ISSUE 9. P. 817 -823 | 14 | 74% | 0 |
9 | VUKOVIC, O , JASOVIC-GASIC, M , PROSTRAN, M , DAMJANOVIC, A , CVETIC, T , BRITVIC, D , MARIC, NP , (2009) EFFICACY, TOLERABILITY AND SAFETY OF TIANEPTINE IN SPECIAL POPULATIONS OF DEPRESSIVE PATIENTS.PSYCHIATRIA DANUBINA. VOL. 21. ISSUE 2. P. 194-198 | 13 | 87% | 2 |
10 | SILVA, JACE , RUSCHEL, SI , CAETANO, D , ROCHA, FL , LIPPI, JRD , ARRUDA, S , OZUN, M , (1997) PLACEBO-CONTROLLED STUDY OF TIANEPTINE IN MAJOR DEPRESSIVE EPISODES.NEUROPSYCHOBIOLOGY. VOL. 35. ISSUE 1. P. 24-29 | 16 | 94% | 23 |
Classes with closest relation at Level 1 |